NCT00027989View on ClinicalTrials.gov

Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

December 31, 2001

Conditions
Breast Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (6)

20735

Oncology-Hematology Associates, P.A., Clinton

29201

South Carolina Oncology Associates, Columbia

29203

South Carolina Oncology Associates, Columbia

36106

Montgomery Cancer Center, Montgomery

80203

Pharmatech Oncology, Denver

91790

California Cancer Medical Center, West Covina

Sponsors
All Listed Sponsors
lead

Pharmatech Oncology

INDUSTRY

NCT00027989 - Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter